Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0000905148-24-002244

Options or other derivatives

  • President and CEO returned 25,755 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Touchon Pascal · President and CEO

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2024-08-12 Returned to the company : show line 1 in the form Employee Stock Option (Right to Buy) −9,000 0 D
2024-08-12 Returned to the company : show line 2 in the form Employee Stock Option (Right to Buy) −9,680 0 D
2024-08-12 Returned to the company : show line 3 in the form Employee Stock Option (Right to Buy) −7,075 0 D
Loading xslF345X05/form4.xml…